Cargando…
The European mesothelioma epidemic
Projections for the period 1995–2029 suggest that the number of men dying from mesothelioma in Western Europe each year will almost double over the next 20 years, from 5000 in 1998 to about 9000 around 2018, and then decline, with a total of about a quarter of a million deaths over the next 35 years...
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362439/ https://www.ncbi.nlm.nih.gov/pubmed/10027347 http://dx.doi.org/10.1038/sj.bjc.6690105 |
_version_ | 1782153454071840768 |
---|---|
author | Peto, J Decarli, A Vecchia, C La Levi, F Negri, E |
author_facet | Peto, J Decarli, A Vecchia, C La Levi, F Negri, E |
author_sort | Peto, J |
collection | PubMed |
description | Projections for the period 1995–2029 suggest that the number of men dying from mesothelioma in Western Europe each year will almost double over the next 20 years, from 5000 in 1998 to about 9000 around 2018, and then decline, with a total of about a quarter of a million deaths over the next 35 years. The highest risk will be suffered by men born around 1945–50, of whom about 1 in 150 will die of mesothelioma. Asbestos use in Western Europe remained high until 1980, and substantial quantities are still used in several European countries. These projections are based on the fit of a simple age and birth cohort model to male pleural cancer mortality from 1970 to 1989 for six countries (Britain, France, Germany, Italy, The Netherlands and Switzerland) which together account for three-quarters of the population of Western Europe. The model was tested by comparing observed and predicted numbers of deaths for the period 1990–94. The ratio of mesothelioma to recorded pleural cancer mortality has been 1.6:1 in Britain but was assumed to be 1:1 in other countries. © 1999 Cancer Research Campaign |
format | Text |
id | pubmed-2362439 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1999 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-23624392009-09-10 The European mesothelioma epidemic Peto, J Decarli, A Vecchia, C La Levi, F Negri, E Br J Cancer Regular Article Projections for the period 1995–2029 suggest that the number of men dying from mesothelioma in Western Europe each year will almost double over the next 20 years, from 5000 in 1998 to about 9000 around 2018, and then decline, with a total of about a quarter of a million deaths over the next 35 years. The highest risk will be suffered by men born around 1945–50, of whom about 1 in 150 will die of mesothelioma. Asbestos use in Western Europe remained high until 1980, and substantial quantities are still used in several European countries. These projections are based on the fit of a simple age and birth cohort model to male pleural cancer mortality from 1970 to 1989 for six countries (Britain, France, Germany, Italy, The Netherlands and Switzerland) which together account for three-quarters of the population of Western Europe. The model was tested by comparing observed and predicted numbers of deaths for the period 1990–94. The ratio of mesothelioma to recorded pleural cancer mortality has been 1.6:1 in Britain but was assumed to be 1:1 in other countries. © 1999 Cancer Research Campaign Nature Publishing Group 1999-02 /pmc/articles/PMC2362439/ /pubmed/10027347 http://dx.doi.org/10.1038/sj.bjc.6690105 Text en Copyright © 1999 Cancer Research Campaign https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Regular Article Peto, J Decarli, A Vecchia, C La Levi, F Negri, E The European mesothelioma epidemic |
title | The European mesothelioma epidemic |
title_full | The European mesothelioma epidemic |
title_fullStr | The European mesothelioma epidemic |
title_full_unstemmed | The European mesothelioma epidemic |
title_short | The European mesothelioma epidemic |
title_sort | european mesothelioma epidemic |
topic | Regular Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362439/ https://www.ncbi.nlm.nih.gov/pubmed/10027347 http://dx.doi.org/10.1038/sj.bjc.6690105 |
work_keys_str_mv | AT petoj theeuropeanmesotheliomaepidemic AT decarlia theeuropeanmesotheliomaepidemic AT vecchiacla theeuropeanmesotheliomaepidemic AT levif theeuropeanmesotheliomaepidemic AT negrie theeuropeanmesotheliomaepidemic AT petoj europeanmesotheliomaepidemic AT decarlia europeanmesotheliomaepidemic AT vecchiacla europeanmesotheliomaepidemic AT levif europeanmesotheliomaepidemic AT negrie europeanmesotheliomaepidemic |